SecBot SecBot
SECBOTREPLAY Home › Report › BCAX

BCAX · Three top executives at Bicara Therapeutics, including the CEO, CFO,…

Bicara Therapeutics Inc. · CLUSTER filed Apr 14, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 5/10

CLUSTER filed Apr 14, 2026 at 20:00 ET

Three top executives at Bicara Therapeutics, including the CEO, CFO, and President/COO, collectively sold $750K worth of shares in open-market transactions over a 7-day period. These sales coincide with recent option exercises, suggesting planned equity monetization rather than reactive selling.

  • CEO Mazumdar Claire sold $354K of shares, following option exercises totaling over $93K in value.
  • CFO Hyep Ivan sold $212K of shares, preceded by derivative exercises worth $34.9K.
  • President and COO Cohlhepp Ryan sold $184K of shares on April 15.
  • Total insider sales: $750K over 7 days, representing 0.05% of the company's $1.5B market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access